Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Titel:
Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Auteur:
Karakas, Mahir Akin, Ibrahim Burdelski, Christoph Clemmensen, Peter Grahn, Hanno Jarczak, Dominik Keßler, Mirjam Kirchhof, Paulus Landmesser, Ulf Lezius, Susanne Lindner, Diana Mebazaa, Alexandre Nierhaus, Axel Ocak, Anil Rottbauer, Wolfgang Sinning, Christoph Skurk, Carsten Söffker, Gerold Westermann, Dirk Zapf, Antonia Zengin, Elvin Zeller, Tanja Kluge, Stefan